nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—CYP2D6—Parkinson's disease	0.524	0.583	CbGaD
Mifepristone—ABCB1—Parkinson's disease	0.374	0.417	CbGaD
Mifepristone—PGR—hindbrain—Parkinson's disease	0.000877	0.0804	CbGeAlD
Mifepristone—NR3C1—nerve—Parkinson's disease	0.000676	0.0619	CbGeAlD
Mifepristone—NR3C1—hindbrain—Parkinson's disease	0.000506	0.0464	CbGeAlD
Mifepristone—PGR—cardiovascular system—Parkinson's disease	0.00041	0.0376	CbGeAlD
Mifepristone—AR—forebrain—Parkinson's disease	0.000386	0.0354	CbGeAlD
Mifepristone—CYP2D6—hindbrain—Parkinson's disease	0.000377	0.0345	CbGeAlD
Mifepristone—AR—cardiovascular system—Parkinson's disease	0.000327	0.0299	CbGeAlD
Mifepristone—NR3C1—embryo—Parkinson's disease	0.000316	0.029	CbGeAlD
Mifepristone—NR3C1—brainstem—Parkinson's disease	0.00029	0.0266	CbGeAlD
Mifepristone—NR3C1—forebrain—Parkinson's disease	0.00028	0.0257	CbGeAlD
Mifepristone—PGR—head—Parkinson's disease	0.000278	0.0255	CbGeAlD
Mifepristone—PGR—nervous system—Parkinson's disease	0.000263	0.0241	CbGeAlD
Mifepristone—PGR—central nervous system—Parkinson's disease	0.000254	0.0232	CbGeAlD
Mifepristone—AR—spinal cord—Parkinson's disease	0.000249	0.0228	CbGeAlD
Mifepristone—PGR—cerebellum—Parkinson's disease	0.000248	0.0227	CbGeAlD
Mifepristone—NR3C1—cardiovascular system—Parkinson's disease	0.000237	0.0217	CbGeAlD
Mifepristone—AR—head—Parkinson's disease	0.000221	0.0203	CbGeAlD
Mifepristone—CYP2D6—brainstem—Parkinson's disease	0.000216	0.0198	CbGeAlD
Mifepristone—AR—nervous system—Parkinson's disease	0.00021	0.0192	CbGeAlD
Mifepristone—CYP2D6—forebrain—Parkinson's disease	0.000208	0.0191	CbGeAlD
Mifepristone—NR3C1—medulla oblongata—Parkinson's disease	0.000202	0.0185	CbGeAlD
Mifepristone—AR—central nervous system—Parkinson's disease	0.000202	0.0185	CbGeAlD
Mifepristone—PGR—brain—Parkinson's disease	0.000201	0.0184	CbGeAlD
Mifepristone—ABCC1—cerebellum—Parkinson's disease	0.000188	0.0172	CbGeAlD
Mifepristone—NR3C1—midbrain—Parkinson's disease	0.000185	0.0169	CbGeAlD
Mifepristone—NR3C1—spinal cord—Parkinson's disease	0.00018	0.0165	CbGeAlD
Mifepristone—ABCB1—embryo—Parkinson's disease	0.000169	0.0155	CbGeAlD
Mifepristone—AR—brain—Parkinson's disease	0.00016	0.0147	CbGeAlD
Mifepristone—NR3C1—head—Parkinson's disease	0.00016	0.0147	CbGeAlD
Mifepristone—ABCC1—brain—Parkinson's disease	0.000152	0.014	CbGeAlD
Mifepristone—NR3C1—nervous system—Parkinson's disease	0.000152	0.0139	CbGeAlD
Mifepristone—ABCB1—forebrain—Parkinson's disease	0.00015	0.0137	CbGeAlD
Mifepristone—NR3C1—central nervous system—Parkinson's disease	0.000146	0.0134	CbGeAlD
Mifepristone—NR3C1—cerebellum—Parkinson's disease	0.000143	0.0131	CbGeAlD
Mifepristone—ABCB1—cardiovascular system—Parkinson's disease	0.000127	0.0116	CbGeAlD
Mifepristone—CYP2D6—head—Parkinson's disease	0.000119	0.0109	CbGeAlD
Mifepristone—NR3C1—brain—Parkinson's disease	0.000116	0.0106	CbGeAlD
Mifepristone—CYP3A4—nervous system—Parkinson's disease	0.000115	0.0105	CbGeAlD
Mifepristone—CYP2D6—nervous system—Parkinson's disease	0.000113	0.0104	CbGeAlD
Mifepristone—CYP3A4—central nervous system—Parkinson's disease	0.000111	0.0101	CbGeAlD
Mifepristone—CYP2D6—central nervous system—Parkinson's disease	0.000109	0.00998	CbGeAlD
Mifepristone—ABCB1—medulla oblongata—Parkinson's disease	0.000108	0.00992	CbGeAlD
Mifepristone—CYP2D6—cerebellum—Parkinson's disease	0.000106	0.00975	CbGeAlD
Mifepristone—ABCB1—midbrain—Parkinson's disease	9.89e-05	0.00907	CbGeAlD
Mifepristone—ABCB1—spinal cord—Parkinson's disease	9.65e-05	0.00885	CbGeAlD
Mifepristone—CYP2D6—brain—Parkinson's disease	8.64e-05	0.00792	CbGeAlD
Mifepristone—ABCB1—head—Parkinson's disease	8.58e-05	0.00786	CbGeAlD
Mifepristone—ABCB1—nervous system—Parkinson's disease	8.13e-05	0.00746	CbGeAlD
Mifepristone—AR—Gene Expression—RPL23A—Parkinson's disease	7.86e-05	0.000868	CbGpPWpGaD
Mifepristone—AR—Gene Expression—RPL14—Parkinson's disease	7.86e-05	0.000868	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	7.85e-05	0.000866	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	7.83e-05	0.000864	CbGpPWpGaD
Mifepristone—ABCB1—central nervous system—Parkinson's disease	7.83e-05	0.00718	CbGeAlD
Mifepristone—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	7.78e-05	0.000858	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	7.74e-05	0.000854	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.73e-05	0.000853	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—HSPA8—Parkinson's disease	7.71e-05	0.000851	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—CTGF—Parkinson's disease	7.68e-05	0.000847	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PDYN—Parkinson's disease	7.68e-05	0.000847	CbGpPWpGaD
Mifepristone—ABCB1—cerebellum—Parkinson's disease	7.65e-05	0.00702	CbGeAlD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.56e-05	0.000834	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GBA—Parkinson's disease	7.54e-05	0.000832	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—FBP1—Parkinson's disease	7.54e-05	0.000832	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—DBH—Parkinson's disease	7.54e-05	0.000832	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	7.49e-05	0.000826	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	7.48e-05	0.000826	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	7.47e-05	0.000824	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	7.37e-05	0.000814	CbGpPWpGaD
Mifepristone—AR—Gene Expression—RPS8—Parkinson's disease	7.33e-05	0.000809	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.25e-05	0.0008	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GFAP—Parkinson's disease	7.22e-05	0.000796	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.21e-05	0.000796	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ND3—Parkinson's disease	7.19e-05	0.000794	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MCCC1—Parkinson's disease	7.19e-05	0.000794	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GRM5—Parkinson's disease	7.14e-05	0.000788	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	7.12e-05	0.000785	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—HSPA1A—Parkinson's disease	7.02e-05	0.000775	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	6.81e-05	0.000751	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TNF—Parkinson's disease	6.79e-05	0.000749	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TALDO1—Parkinson's disease	6.76e-05	0.000746	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—OMD—Parkinson's disease	6.76e-05	0.000746	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.71e-05	0.00074	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	6.57e-05	0.000725	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	6.55e-05	0.000722	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	6.41e-05	0.000707	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—DDC—Parkinson's disease	6.35e-05	0.0007	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.31e-05	0.000696	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGF20—Parkinson's disease	6.26e-05	0.000691	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RPL14—Parkinson's disease	6.26e-05	0.00069	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RPL23A—Parkinson's disease	6.26e-05	0.00069	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL6—Parkinson's disease	6.24e-05	0.000688	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	6.22e-05	0.000687	CbGpPWpGaD
Mifepristone—ABCB1—brain—Parkinson's disease	6.22e-05	0.0057	CbGeAlD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.14e-05	0.000677	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GCH1—Parkinson's disease	6.12e-05	0.000675	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ADORA2A—Parkinson's disease	6.07e-05	0.00067	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.05e-05	0.000668	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTA4—Parkinson's disease	5.99e-05	0.000661	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RPL14—Parkinson's disease	5.97e-05	0.000658	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RPL23A—Parkinson's disease	5.97e-05	0.000658	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	5.92e-05	0.000653	CbGpPWpGaD
Mifepristone—AR—Gene Expression—HSPA8—Parkinson's disease	5.88e-05	0.000648	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	5.86e-05	0.000647	CbGpPWpGaD
Mifepristone—AR—Gene Expression—CTGF—Parkinson's disease	5.85e-05	0.000645	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGF20—Parkinson's disease	5.83e-05	0.000644	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RPS8—Parkinson's disease	5.83e-05	0.000644	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—INSR—Parkinson's disease	5.6e-05	0.000618	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RPS8—Parkinson's disease	5.56e-05	0.000614	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—DDC—Parkinson's disease	5.54e-05	0.000611	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.48e-05	0.000605	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—IL6—Parkinson's disease	5.48e-05	0.000604	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—FBP1—Parkinson's disease	5.45e-05	0.000601	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GBA—Parkinson's disease	5.45e-05	0.000601	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—DBH—Parkinson's disease	5.45e-05	0.000601	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TNF—Parkinson's disease	5.43e-05	0.000599	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ND3—Parkinson's disease	5.43e-05	0.000599	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MCCC1—Parkinson's disease	5.43e-05	0.000599	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PLA2G6—Parkinson's disease	5.4e-05	0.000595	CbGpPWpGaD
Mifepristone—AR—Gene Expression—HSPA1A—Parkinson's disease	5.35e-05	0.00059	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MAOB—Parkinson's disease	5.34e-05	0.000589	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGB—Parkinson's disease	5.29e-05	0.000584	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HTR1A—Parkinson's disease	5.27e-05	0.000581	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTA4—Parkinson's disease	5.23e-05	0.000577	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TAC1—Parkinson's disease	5.19e-05	0.000572	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.16e-05	0.000569	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.13e-05	0.000566	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.12e-05	0.000565	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.12e-05	0.000564	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ND3—Parkinson's disease	5.12e-05	0.000564	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TALDO1—Parkinson's disease	5.1e-05	0.000563	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—OMD—Parkinson's disease	5.1e-05	0.000563	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.09e-05	0.000561	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—DRD1—Parkinson's disease	5.09e-05	0.000561	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.08e-05	0.000561	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.06e-05	0.000558	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	5.04e-05	0.000557	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—DRD3—Parkinson's disease	4.93e-05	0.000543	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NDUFB11—Parkinson's disease	4.84e-05	0.000534	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—OMD—Parkinson's disease	4.81e-05	0.000531	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.81e-05	0.000531	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.73e-05	0.000522	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.72e-05	0.00052	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	4.71e-05	0.000519	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MAOB—Parkinson's disease	4.66e-05	0.000514	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.65e-05	0.000513	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GCH1—Parkinson's disease	4.62e-05	0.000509	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ADRBK1—Parkinson's disease	4.6e-05	0.000507	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.56e-05	0.000503	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—HSPA8—Parkinson's disease	4.46e-05	0.000492	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—DRD2—Parkinson's disease	4.46e-05	0.000491	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HTR7—Parkinson's disease	4.46e-05	0.000491	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—CTGF—Parkinson's disease	4.44e-05	0.00049	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.35e-05	0.00048	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ADRBK1—Parkinson's disease	4.29e-05	0.000473	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HSPA1A—Parkinson's disease	4.26e-05	0.00047	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GBA—Parkinson's disease	4.11e-05	0.000454	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—FBP1—Parkinson's disease	4.11e-05	0.000454	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—DBH—Parkinson's disease	4.11e-05	0.000454	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—HSPA1A—Parkinson's disease	4.06e-05	0.000448	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—DDC—Parkinson's disease	4e-05	0.000441	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP2D6—Parkinson's disease	3.97e-05	0.000438	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CTGF—Parkinson's disease	3.9e-05	0.00043	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GBA—Parkinson's disease	3.88e-05	0.000428	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.88e-05	0.000428	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—DBH—Parkinson's disease	3.88e-05	0.000428	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTA4—Parkinson's disease	3.78e-05	0.000417	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF2—Parkinson's disease	3.73e-05	0.000412	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.68e-05	0.000406	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP2E1—Parkinson's disease	3.63e-05	0.000401	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF1R—Parkinson's disease	3.61e-05	0.000398	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.59e-05	0.000397	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NQO1—Parkinson's disease	3.59e-05	0.000396	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EDN1—Parkinson's disease	3.57e-05	0.000393	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TH—Parkinson's disease	3.54e-05	0.00039	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	3.46e-05	0.000382	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.45e-05	0.000381	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	3.4e-05	0.000375	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CTGF—Parkinson's disease	3.4e-05	0.000375	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYCS—Parkinson's disease	3.4e-05	0.000375	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.39e-05	0.000374	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MAOB—Parkinson's disease	3.37e-05	0.000372	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ND3—Parkinson's disease	3.34e-05	0.000369	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.34e-05	0.000369	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NGF—Parkinson's disease	3.28e-05	0.000362	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	3.17e-05	0.000349	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.14e-05	0.000347	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—OMD—Parkinson's disease	3.14e-05	0.000347	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NQO1—Parkinson's disease	3.13e-05	0.000345	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HTR2A—Parkinson's disease	3.12e-05	0.000344	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TH—Parkinson's disease	3.09e-05	0.000341	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—DDC—Parkinson's disease	3.02e-05	0.000333	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—COMT—Parkinson's disease	3.01e-05	0.000332	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3e-05	0.000331	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTP1—Parkinson's disease	2.99e-05	0.00033	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MAOA—Parkinson's disease	2.99e-05	0.00033	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.98e-05	0.000329	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYCS—Parkinson's disease	2.96e-05	0.000327	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—HMOX1—Parkinson's disease	2.95e-05	0.000326	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MTHFR—Parkinson's disease	2.9e-05	0.00032	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APOE—Parkinson's disease	2.9e-05	0.00032	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.85e-05	0.000315	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—DDC—Parkinson's disease	2.85e-05	0.000314	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.84e-05	0.000314	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ABCB1—Parkinson's disease	2.83e-05	0.000313	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTM1—Parkinson's disease	2.75e-05	0.000304	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APOE—Parkinson's disease	2.7e-05	0.000298	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.69e-05	0.000296	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.68e-05	0.000296	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GPX1—Parkinson's disease	2.64e-05	0.000291	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—COMT—Parkinson's disease	2.62e-05	0.00029	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTP1—Parkinson's disease	2.61e-05	0.000288	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MAOA—Parkinson's disease	2.61e-05	0.000287	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—HMOX1—Parkinson's disease	2.58e-05	0.000284	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.57e-05	0.000283	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MAOB—Parkinson's disease	2.54e-05	0.00028	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.53e-05	0.00028	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—DBH—Parkinson's disease	2.53e-05	0.00028	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GBA—Parkinson's disease	2.53e-05	0.00028	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	2.5e-05	0.000276	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—INS—Parkinson's disease	2.48e-05	0.000273	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ABCB1—Parkinson's disease	2.47e-05	0.000273	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CTGF—Parkinson's disease	2.46e-05	0.000271	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MTHFR—Parkinson's disease	2.43e-05	0.000268	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.42e-05	0.000267	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTM1—Parkinson's disease	2.4e-05	0.000265	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.4e-05	0.000264	CbGpPWpGaD
Mifepristone—ABCC1—Disease—INS—Parkinson's disease	2.31e-05	0.000255	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GPX1—Parkinson's disease	2.3e-05	0.000254	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	2.29e-05	0.000253	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—APOE—Parkinson's disease	2.26e-05	0.00025	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NQO1—Parkinson's disease	2.26e-05	0.00025	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TH—Parkinson's disease	2.23e-05	0.000246	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYCS—Parkinson's disease	2.14e-05	0.000236	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MTHFR—Parkinson's disease	2.12e-05	0.000234	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—APOE—Parkinson's disease	1.97e-05	0.000218	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—INS—Parkinson's disease	1.93e-05	0.000213	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—COMT—Parkinson's disease	1.9e-05	0.000209	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.89e-05	0.000208	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTP1—Parkinson's disease	1.89e-05	0.000208	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MAOA—Parkinson's disease	1.88e-05	0.000208	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—HMOX1—Parkinson's disease	1.86e-05	0.000205	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—DDC—Parkinson's disease	1.86e-05	0.000205	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CTGF—Parkinson's disease	1.85e-05	0.000205	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CASP3—Parkinson's disease	1.85e-05	0.000204	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ABCB1—Parkinson's disease	1.79e-05	0.000197	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.76e-05	0.000194	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.75e-05	0.000193	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTM1—Parkinson's disease	1.74e-05	0.000191	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.73e-05	0.000191	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NQO1—Parkinson's disease	1.71e-05	0.000188	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK8—Parkinson's disease	1.7e-05	0.000187	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—INS—Parkinson's disease	1.69e-05	0.000186	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TH—Parkinson's disease	1.68e-05	0.000186	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GPX1—Parkinson's disease	1.66e-05	0.000183	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.63e-05	0.00018	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYCS—Parkinson's disease	1.62e-05	0.000178	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.61e-05	0.000178	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TH—Parkinson's disease	1.59e-05	0.000175	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.58e-05	0.000175	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.57e-05	0.000173	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MTHFR—Parkinson's disease	1.53e-05	0.000169	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.52e-05	0.000168	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—COMT—Parkinson's disease	1.43e-05	0.000158	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOE—Parkinson's disease	1.43e-05	0.000157	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.42e-05	0.000157	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MAOA—Parkinson's disease	1.42e-05	0.000157	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.41e-05	0.000155	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—COMT—Parkinson's disease	1.35e-05	0.000149	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.34e-05	0.000148	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.34e-05	0.000148	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.32e-05	0.000146	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.31e-05	0.000144	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.27e-05	0.00014	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GPX1—Parkinson's disease	1.25e-05	0.000138	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.23e-05	0.000136	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—INS—Parkinson's disease	1.22e-05	0.000135	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.18e-05	0.00013	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.16e-05	0.000128	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.16e-05	0.000128	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.14e-05	0.000126	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.09e-05	0.00012	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—Parkinson's disease	1.08e-05	0.000119	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOE—Parkinson's disease	1.08e-05	0.000119	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.06e-05	0.000117	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.05e-05	0.000116	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TH—Parkinson's disease	1.04e-05	0.000114	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOE—Parkinson's disease	1.02e-05	0.000112	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—Parkinson's disease	1.01e-05	0.000111	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYCS—Parkinson's disease	9.96e-06	0.00011	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—INS—Parkinson's disease	9.2e-06	0.000102	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—COMT—Parkinson's disease	8.82e-06	9.73e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.78e-06	9.68e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MAOA—Parkinson's disease	8.76e-06	9.66e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—INS—Parkinson's disease	8.67e-06	9.57e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HMOX1—Parkinson's disease	8.66e-06	9.55e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.31e-06	9.17e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.07e-06	8.9e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.72e-06	8.52e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.13e-06	7.86e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOE—Parkinson's disease	6.64e-06	7.32e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—INS—Parkinson's disease	5.67e-06	6.26e-05	CbGpPWpGaD
